Chat with us, powered by LiveChat
Home Our Attorneys Thomas M. Comerford
Thomas M. Comerford

Thomas M. Comerford

Associate Attorney

Focus: Mesothelioma and Asbestos

Phone: (212) 558-5500

Fax: (212) 344-5461

New York Office: 700 Broadway
New York, NY 10003

Get In Touch
Biography
Presentations & Publications
Biography
Biography
Presentations & Publications

Get to know Thomas M.

Education
  • J.D., Washington College of Law at The American University, 1998
  • M.P.A., George Washington University, 1995
  • B.A., Colgate University, 1993
Bar Admissions
  • New Jersey
  • New York
  • District of Columbia

Biography

The practice of law in the context of mass-tort litigation is, in practical reality, a dynamic, communal activity, and necessarily so, for the needs of our clients demand a law firm capable of highly focused, precise, and timely legal work to right the devastating wrongs they have experienced at the hands of those interests responsible. Weitz & Luxenberg has assembled a uniquely effective, collegial, litigation team that is equipped to provide meaningful help to our clients and their families who demand justice. I am honored to have a hand in it.”

Thomas M. Comerford joined Weitz & Luxenberg in 2001 as an associate attorney in our Asbestos Litigation group. Before coming to the firm, he clerked in the chambers of the Hon. Burrell Ives Humphreys of the New Jersey Superior Court.

Mr. Comerford is admitted to practice law in three jurisdictions: New Jersey, New York, and the District of Columbia. He received a juris doctor degree from the Washington College of Law at The American University in 1998; a masters of Public Administration degree from the George Washington University in 1995; and completed his undergraduate studies majoring with honors in history at Colgate University in 1993.

Education
  • J.D., Washington College of Law at The American University, 1998
  • M.P.A., George Washington University, 1995
  • B.A., Colgate University, 1993
Bar Admissions
  • New Jersey
  • New York
  • District of Columbia

Awards & Honors

Key Verdicts

Presentations & Publications

  • with Golanski, A., The Speculation Economy: How Finance Triumphed Over Industry by Lawrence E. Mitchell, New York Law Journal (Feb. 17, 2009)
Request A Free Consultation

"*" indicates required fields

Disclaimer*
Your consent to contact is not required. To proceed without providing consent,  please call us at (855) 930-5906. 

  1. U.S. Food & Drug Administration. (2017, August 25). Medical Devices. Recalls, Corrections and Removals (Devices) Retrieved from
    https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/RecallsCorrectionsAndRemovals/default.htm
  2. U.S. Government Accountability Office. (2015, June 30). Medical Device Companies: Trends in Reported Net Sales and Profits Before and After Implementation of the Patient Protection and Affordable Care Act. Retrieved from
    http://www.gao.gov/products/GAO-15-635R
  3. U.S. Food & Drug Administration. (2017, January 25). Medical Devices. 510(k) Clearances. Retrieved from
    https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/
  4. U.S. Food & Drug Administration. (2017, June 30). MAUDE – Manufacturer and User Facility Device Experience. Retrieved from
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
  5. The Wall Street Journal. (2014). How Morcellation, a Common Procedure, Spread Cancer in Hysterectomy Patients. Retrieved from
    http://www.wsj.com/morcellation
  6. U.S. Government Accountability Office. (2017, February). Medical Devices. Cancer Risk Led FDA to Warn Against Certain Uses of Power Morcellators and Recommend New Labeling. Retrieved from
    http://www.gao.gov/assets/690/682573.pdf
  7. U.S. Food & Drug Administration. (2017, January 25). Medical Devices. List of Device Recalls. Retrieved from https://www.fda.gov/medicaldevices/safety/listofrecalls/
  8. U.S. Food & Drug Administration. (2017, February 2). Medical Devices. Metal-on-Metal Hip Implant Systems. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/ucm241601.htm
  9. Berber, R., et al. (2016, May 18). Management of metal-on-metal hip implant patients: Who, when and how to revise? Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865716/
  10. U.S. Food & Drug Administration. (2016, November 25). Medical Devices. Metal-on-Metal Hip Implants: FDA Activities. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241769.htm
  11. U.S. Food & Drug Administration. (2017, February 8). Information for Patients Who Have Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241766.htm#13
  12. U.S. Food & Drug Administration. (2015, April 10). Medical Devices. Concerns about Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
  13. Oliveira, C.A., et al. (2014, November 28). Metallosis: A diagnosis not only in patients with metal-on-metal prostheses. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26937430
  14. U.S. Food & Drug Administration. (2015, April 10). Medical Devices. Concerns about Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
  15. Penn Medicine. Abramson Cancer Center. (n.d.). Types of Mesothelioma or Pleural Disease. Retrieved from https://webcache.googleusercontent.com/search?q=cache:GyCrbtitgHwJ:https://ora.ox.ac.uk/objects/uuid:842f7ea5-19a6-44b6-bc03-23a9e836a036/datastreams/content01+&cd=3&hl=en&ct=clnk&gl=us
  16. Drummond, J., et al. (2015, June 26). Metal-on-Metal Hip Arthroplasty: A Review of Adverse Reactions and Patient Management. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598667/
  17. Krochtengel, J. (2016, December 2). Huge Verdicts Won’t Spur Settlement Talks in J&J Hip MDL. Retrieved from https://www.law360.com/articles/868311/huge-verdicts-won-t-spur-settlement-talks-in-j-j-hip-mdl
  18. Koch, C.N., et al. (2016, October). Spontaneous Fractures of a Modern Modular Uncemented Femoral Stem. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27703419
  19. Stronach, B.M., et al. (2016, March). Failure of Emperion modular femoral stem with implant analysis. Retrieved from http://www.arthroplastytoday.org/article/S2352-3441(15)00080-1/fulltext
  20. Shah, R.R., et al. (2017, October). Alarmingly High Rate of Implant Fractures in One Modular Femoral Stem Design: A Comparison of Two Implants. Retrieved from http://www.arthroplastyjournal.org/article/S0883-5403(17)30470-9/fulltext
  21. Australian Orthopaedic Association National Joint Replacement Registry. South Australian Health and Medical Research Institute Ltd. (2016, September). Emperion Total Conventional Hip Investigation. Retrieved from https://aoanjrr.sahmri.com/documents/10180/277147/Emperion%20Femoral%20Stem
  22. Smith & Nephew Inc. (2016, November 15). Urgent Field Safety Notice: Medical Device Field Safety Corrective Action/Recall. Retrieved from http://www.bfarm.de/SharedDocs/Kundeninfos/EN/11/2016/09832-16_Kundeninfo_en.pdf;jsessionid=A90BEC524676E62D9943FE20B8C99B1C.1_cid350?__blob=publicationFile&v=1
  23. O’Sullivan, J. (2016, December 19). Stryker Adds Patients To $1B Hip Implant Settlement. Retrieved from https://www.law360.com/articles/874540/stryker-adds-patients-to-1b-hip-implant-settlement
  24. U.S. Food & Drug Administration. (2017, July 19). Class 2 Device Recall. Stryker LFIT Anatomic V40 Femoral Head. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=149782
  25. U.S. Judicial Panel on Multidistrict Litigation. (2017, April 5). In Re: Stryker Orthopaedics LFIT V40 Femoral Head Products Liability Litigation. MDL No. 2768. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2768-Initial_Transfer-03-17.pdf
  26. Ibid.
  27. Field, E. (2016, November 2). Wright Medical Technology Agrees to $240M Hip Implant Deal. Retrieved from https://www.law360.com/articles/858934
  28. U.S. Food & Drug Administration. (2015, October 2). Safety. Profemur Neck Varus/Valgus CoCr 8 Degree, Part number PHAC 1254 by MicroPort Orthopedics: Class I Recall - Unexpected Rate of Fractures After Surgery. Retrieved from https://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm465529.htm
  29. MicroPort. (2013, June 25). MicroPort Scientific Corporation and Wright Medical Group, Inc. Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright's OrthoRecon Business. Retrieved from http://www.microport.com.cn/en/media.php?curr_page=news_details&id=199
  30. U.S. Food & Drug Administration. (2009, June 24). Safety. Background and Definitions. Retrieved from https://www.fda.gov/Safety/Recalls/ucm165546.htm
  31. U.S. Food & Drug Administration. (2015, October 2). Safety. Profemur Neck Varus/Valgus CoCr 8 Degree, Part Number PHAC 1254 by MicroPort Orthopedics: Class I Recall – Unexpected Rate of Fractures After Surgery. Retrieved from https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm465529.htm
  32. U.S. National Library of Medicine. MedlinePlus. (2015, July 13). Risks of hip and knee replacement. Retrieved from https://medlineplus.gov/ency/patientinstructions/000375.htm
  33. U.S. Food & Drug Administration. (2017, July 19). Medical Device Recalls. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=55876
  34. U.S. Food & Drug Administration. (2017, July 19). Medical Device Recalls. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=57178
  35. U.S. Judicial Panel on Multidistrict Litigation. (2017, June 15). MDL Statistics Report – Distribution of Pending MDL Dockets by District (ILN). MDL-2272. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-15-2017.pdf
  36. U.S. Food & Drug Administration. (2017, July 19). Class 2 Device Recall. Persona Trabecular Metal Tibial Plate/Persona TM Tibia. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=133978
  37. Smith & Nephew, Inc. (2018, June 13). Urgent Field Safety Notice. Retrieved from https://www.mcgartland.com/wp-content/uploads/2018/07/Smith-Nephew-Field-Safety-Notice-Journey-BCS-Knee.pdf
  38. U.S. Food & Drug Administration. (2018, October 1). Class 2 Device Recall. Journey BCS Knee System. Retrieved from https://www.accessdata.fda.gov/SCRIPTs/cdrh/cfdocs/cfres/res.cfm?id=165170
  39. Ibid.
  40. Eisner, W. (2018, August 8). Orthopedics This Week. Safety Notice for S&N Journey BSC (sic) Knee. Retrieved from https://ryortho.com/breaking/safety-notice-for-sn-journey-bsc-knee/
  41. Ranawat, A. S. (2010, April 14). Revision Total Knee Replacement: Frequently Asked Questions. Retrieved from https://www.hss.edu/conditions_revision-total-knee-replacement-faqs.asp
  42. American Academy of Orthopaedic Surgeons. (2015, May). Revision Total Knee Replacement. Retrieved from https://orthoinfo.aaos.org/en/treatment/revision-total-knee-replacement/
  43. Bohsali, K., et al. (2017, February 1). Complications of Shoulder Arthroplasty. Retrieved from https://web.archive.org/web/20190903052402/http://journals.lww.com/jbjsjournal/Abstract/2017/02010/Complications_of_Shoulder_Arthroplasty.10.aspx
  44. U.S. Food & Drug Administration. (2017, April 4). Medical Devices. Hernia Surgical Mesh Implants. Retrieved from https://web.archive.org/web/20190903052402/https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/HerniaSurgicalMesh/default.htm
  45. U.S. Food & Drug Administration. (n.d.). Medical Devices. Surgical Mesh: FDA Safety Communication. Retrieved from https://web.archive.org/web/20190903052402/https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm142636.htm
  46. Ibid.
  47. U.S. Food & Drug Administration. (2011, July 5). MAUDE Adverse Event Report: Atrium Medical Corporation Atrium C-QUR 4” x 6” Hernia Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=2650980
  48. U.S. Food & Drug Administration. (2017, June 28). MAUDE Adverse Event Report: Davol Inc., Sub. C.R. Bard, Inc. Mesh-Ventralex Surgical Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=6675252&pc=FTL
  49. U.S. Food & Drug Administration. (2017, May 22). MAUDE Adverse Event Report: Johnson & Johnson International Physiomesh Mesh, Surgical. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=6642940&pc=FTL
  50. U.S. Food & Drug Administration. (2017, June 15). MAUDE Adverse Event Report: Covidien/Medtronic Parietex Progrip Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=5774864&pc=KDD